Dec 4 (Reuters) - China Resources Pharmaceutical Group Ltd 3320.HK:
REGISTRATION OF ASSET-BACKED NOTES BY NATIONAL ASSOCIATION OF FINANCIAL MARKET INSTITUTIONAL INVESTORS
CHINA RESOURCES PHARMACEUTICAL COMMERCIAL MAY ISSUE ASSET-BACKED NOTES IN AGGREGATE AMOUNT OF RMB15 BILLION
Further company coverage: 3320.HK
((Reuters.Briefs@thomsonreuters.com;))